Connection
Guido Tricot to Immunologic Factors
This is a "connection" page, showing publications Guido Tricot has written about Immunologic Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.574 |
|
|
|
-
Zangari M, Elice F, Tricot G. Immunomodulatory drugs in multiple myeloma. Expert Opin Investig Drugs. 2005 Nov; 14(11):1411-8.
Score: 0.245
-
Zangari M, Berno T, Zhan F, Tricot G, Fink L. Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugs. Semin Thromb Hemost. 2012 Nov; 38(8):768-79.
Score: 0.099
-
Zangari M, Fink L, Zhan F, Tricot G. Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens. Clin Lymphoma Myeloma Leuk. 2011 Apr; 11(2):228-36.
Score: 0.089
-
Zangari M, Fink LM, Elice F, Zhan F, Adcock DM, Tricot GJ. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol. 2009 Oct 10; 27(29):4865-73.
Score: 0.080
-
Fassas AB, Kiwan E, Roberts J, Burr T, Tricot G, Anaissie E, Barlogie B. Metronomic chemoimmunotherapy in a patient with refractory Waldenstrom's macroglobulinemia. Leuk Lymphoma. 2005 Nov; 46(11):1675-7.
Score: 0.061